Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.
Leuk Lymphoma
; 57(6): 1311-8, 2016.
Article
in En
| MEDLINE
| ID: mdl-26372888
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Azacitidine
/
Myelodysplastic Syndromes
/
Leukemia, Myeloid, Acute
/
Antineoplastic Combined Chemotherapy Protocols
/
Epigenesis, Genetic
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2016
Type:
Article